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Abstract  
Objective: Perivascular adipose tissue (PVAT) wraps blood vessels and modulates 
vasoreactivity by secretion of vasoactive molecules. Mammalian target of rapamycin 
complex 2 (mTORC2) has been shown to control inflammation and is expressed in 
adipose tissue. In this study, we investigated whether adipose-specific deletion of rictor 
and thereby inactivation of mTORC2 in PVAT, may modulate vascular function by 
increasing inflammation in PVAT. 
Approach and Results:  Rictor, an essential mTORC2 component, was deleted 
specifically in mouse adipose tissue (rictorad-/-). Phosphorylation of mTORC2 
downstream target Akt at Serine 473 was reduced in PVAT from rictorad-/- mice but 
unaffected in aortic tissue. Ex vivo functional analysis of thoracic aortae revealed 
increased contractions and impaired dilation in rings with PVAT from rictorad-/- mice. 
Adipose rictor knockout increased gene expression and protein release of interleukin-6, 
macrophage inflammatory protein1α and tumor necrosis factorα in PVAT as shown by 
quantitative real-time PCR and Bioplex-analysis for the cytokines in the conditioned 
media, respectively. Moreover, gene and protein expression of iNOS was upregulated 
without affecting macrophage infiltration in PVAT from rictorad-/- mice.  Inhibition of iNOS 
normalized vascular reactivity in aortic rings from rictorad-/- mice with no effect in rictorfl/fl 
mice. Interestingly, in perivascular and epididymal adipose depots, high-fat diet feeding 
induced downregulation of rictor gene expression. 
Conclusions:  Here, we identify mTORC2 as a critical regulator of PVAT-directed 
protection of normal vascular tone.  Modulation of mTORC2 activity in adipose tissue 
may be a potential therapeutic approach for inflammation-related vascular damage. 
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Introduction 
Adipose tissue not only stores excess of energy as triacylglycerols but also secretes 
numerous growth factors, cytokines and hormones that are involved in overall energy 
homeostasis and metabolism.1  During obesity, adipose tissue mass increases and 
dysfunction occurs favoring development of insulin resistance and cardiovascular 
disease.1  
 A crucial intracellular regulator of fatty acid metabolism and cell growth is the serine/ 
threonine kinase mammalian target of rapamycin (mTOR).2 mTOR exists in two multi-
protein complexes, mTOR complex 1 (mTORC1) and mTORC2.3 The latter complex is 
characterized by its essential regulatory protein rictor and integrates signals from growth 
factors to regulate cell survival or cytoskeleton organization.4-7 mTORC2 phosphorylates 
AGC kinase family members such as Akt at Serine 473.8  
As full body knockout of rictor/ mTORC2 is embryonically lethal, 9 diverse tissue-specific 
knockout models of rictor have been generated to characterize the physiologic functions 
of rictor in the adult mouse.4  Mice with specific ablation of rictor in adipose tissue have 
higher lean mass due to increased levels of insulin and insulin-like growth factor-1, 
display enhanced glucose metabolism and are insulin resistant.10, 11   
Among the various and distinct adipose depots, perivascular adipose tissue (PVAT) not 
only  serves as a structural support for most arteries but  also secretes molecules to 
actively modulate vascular function.12, 13   PVAT has an anticontractile function  and this 
was shown for the first time in 1991 by Soltis and Cassis.14 In 2002, Löhn et al. reported 
the release of a transferable vasoactive factor by PVAT that act on vascular smooth 
muscle cells (VSMCs) via ATP-dependent K+ channels to mediate vasorelaxation.15 
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Since then, the list of  dilatory or anticontractile molecules released from PVAT has 
expanded and  now includes  adipokines (e.g. adiponectin16), reactive oxygen species 
(e.g. hydrogen peroxide17) and others (e.g. methyl palmitate18, hydrogen sulfide19, and 
Angiotensin 1-720). In 2005, Yudkin et al., proposed that obesity and its adverse effects 
causes PVAT to inflame, and to secrete tumor necrosis factor (TNF)α and  interleukin 
(IL)6 which resulted in  loss of  PVAT’s anticontractile function.21 In rat mesenteric 
arteries, these inflammatory cytokines impaired the anticontractile activity of healthy 
PVAT,22  and in mouse femoral arteries, endovascular injury upregulated inflammation in 
PVAT.23 
Thus, the progression of the inflammatory reaction in PVAT appears to be crucial in 
altering PVAT’s vasoactive properties, however, intracellular mechanisms that might 
control these reactions are not known. Recently, mTORC2-deficient mouse embryonic 
fibroblasts and rictor knockdown of dendritic cells exhibited a hyperinflammatory 
phenotype after lipopolysaccharide stimulation.24  In this study, we have therefore tested 
the hypothesis that deletion of rictor in adipose tissue, and thereby inactivation of 
mTORC2 in PVAT, may modulate vascular function by increasing inflammation in PVAT. 
 
Materials and Methods 
Materials and Methods are available in the online-only Supplement. 
 
Results 
Adipose-Specific Deletion of Rictor Attenuates mTORC2 Signaling in Aortic PVAT  
To analyze the role of mTORC2 in PVAT for vascular function, we used adipose cell-
specific rictor knockout (rictorad-/-) and corresponding control (rictorfl/fl ) mice which were 
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described previously.10 Adipose-specific rictor knockout was confirmed by significant 
reduction of rictor gene expression in epididymal fat (EFAT) from rictorad-/- mice 
(Supplemental Figure I). Next, rictor gene expression in aorta (tissue containing mainly 
smooth muscle and endothelial cells) and in PVAT surrounding the thoracic aorta 
(referred henceforth as PVAT) was examined. The expression of rictor was significantly 
reduced in the PVAT but remained unchanged in the aorta from rictorad-/- mice (Figure 
1A). To evaluate mTORC2 activity, aortic rings with intact PVAT were stimulated with 
insulin. Subsequently, PVAT and aorta were separated and analyzed for Akt Ser473 
phosphorylation, a known TORC2 substrate.8  PVAT from rictorad-/- mice exhibited 
reduced Akt Ser473 phosphorylation after insulin stimulation indicating impaired insulin 
signaling (Figure 1B, C). In the aorta, insulin-induced Akt Ser473 phosphorylation 
remained unchanged in the groups (Figure 1B, C). No difference was detected in insulin-
stimulated phosphorylation of Erk1/2 between the mice groups in PVAT and aorta 
(Figure 1B). 
 
Increased Aortic Contraction and Impaired Endothelium-Dependent Relaxation in  
Rictorad-/- Mice in the Presence of PVAT  
PVAT surrounding the arteries influences vascular function.12, 13 To investigate whether 
PVAT from rictorad-/- mice modulate aortic contractions, aortic rings with or without PVAT 
were used. To test the contractile capacity of the smooth muscle cell layer by direct 
depolarization, all rings were initially treated with100 mmol/L potassium chloride (KCl). In 
all rings, similar contractions independent of rictor and PVAT were observed (data not 
shown). Next, we investigated the contribution of rictor in PVAT to receptor-dependent 
vascular contraction. Aortic rings with or without PVAT were exposed to vasoconstrictor 
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phenylephrine (PE) in a concentration-dependent manner. Aortic rings with PVAT from 
rictorad-/- mice displayed 2.1-fold higher maximal contractions as compared with rings 
from rictorfl/fl mice after treatment with PE (rictorad-/- : 43.2±6.3% vs.  rictorfl/fl : 20.1±3.8% 
at 3x10-6  mol/L,   Figure 2A). With the removal of PVAT, contractions to PE increased 
overall and maximal contractions reached similar levels in both groups of mice (rictorad-/- 
: 70.0± 8.6% vs. rictorfl/fl : 81.0±10.1% at 3x10-6  mol/L, Figure 2B). To determine whether 
vascular relaxation was also affected, we analyzed acetylcholine (ACh)-induced 
endothelium-dependent relaxation. ACh-induced relaxation in aortic rings with PVAT 
was impaired in rictorad-/- mice (Figure 2C). This impairment was also confirmed by the 
pD2 values, which suggests a delay in relaxation in rictorad-/- aortic rings with PVAT 
(rictorad-/- : 6.2± 0.2 mol/L vs. rictorfl/fl : 7.0±0.1 mol/L). Upon removal of PVAT, the 
differences were lost and the aortic rings relaxed normally (Figure 2D). As we found 
differences in contraction and dilation to receptor-dependent agonists in rings with 
PVAT, we further characterized contraction to KCl. Concentration-dependent (10 to 100 
mmol/L) KCl-induced contractions in aortic rings with PVAT were similar between both 
groups of mice (Supplemental Figure II). 
Hypothetically, increased aortic contraction with PVAT in rictorad-/- mice might be due to 
reduced nitric oxide (NO) availability from endothelial nitric oxide synthase (eNOS). To 
investigate this L-NAME, which preferentially inhibits eNOS was used.25 In the presence 
of L-NAME (300 µmol/L), the contractile responses to PE increased in rings with PVAT 
from both mice groups (Figure 2E). Nonetheless, PE-induced contractions were higher 
in aortic rings with PVAT from rictorad-/- mice (1.5-fold; rictorad-/- : 86.36±8.17% vs. 
rictorfl/fl: 58.78±6.71% at 3 x10-6  mol/L; Figure 2E). 
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To define the specificity of L-NAME for the different NO synthases we used RAW264.7 
cell line which exclusively expresses inducible NOS, (iNOS/NOS2).26 NO measurements 
after LPS stimulation revealed that L-NAME at 300 µmol/L also partially inhibited iNOS-
induced NO production (approximately 40%, Supplemental Figure III). Expectedly, iNOS 
inhibitor 1400W, a highly specific and selective inhibitor 27, inhibited LPS-induced NO 
production to baseline levels (Supplementary Figure III). 
In addition to NO, endothelium also releases other dilatory factors. Hence, experiments 
were performed with endothelium-denuded aortic rings with PVAT. Aortic contractions to 
PE or PGF2α were significantly higher in rictorad-/- mice compared with rictorfl/fl mice 
(Figure 2F and G). Taken together these results suggest that the anticontractile effect 
mediated by rictor is for the most part endothelium-independent. 
     
Loss of Rictor in Adipose Cells of PVAT Results in Upregulation of Inflammatory 
Mediators  
To determine how loss of rictor in adipose cells of PVAT increases aortic contractions 
and impairs relaxation, we screened genes which are expressed in and secreted by 
PVAT. These included adipokines28, reactive oxygen species (ROS),17, 29 and 
inflammatory molecules.30 Amongst the adipokines, gene expression levels of 
adiponectin (adipoq) and lipocalin (lnc2) were not affected in the PVAT from rictorad-/- 
mice (Figure 3A). However, the expression level of resistin (retn) was significantly 
reduced. Gene expression of NADPH oxidase subunits nox2, nox4, p22phox, and 
p67phox and adipocyte markers (PPARγ and FABP4) were not affected. Interestingly, 
the expression of inflammatory genes such as macrophage inflammatory protein 1α 
(Mip1α) and Tnfα were increased in the PVAT from rictorad-/- mice (Figure 3A).  
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Protein analysis of conditioned media revealed increased release of IL-6 (5-fold), MIP1α 
(5-fold) and TNFα (4-fold) from PVAT of rictorad-/- mice (Figure 3B).  
 
Increased iNOS Expression in PVAT of Rictor ad-/- Mice  
To investigate if the augmented expression of inflammatory molecules was associated 
with elevated macrophage infiltration in PVAT, we determined steady state mRNA 
expression levels of macrophage-associated genes emr1 (F4/80), CD163, and iNos. 
Expression of F4/80 and CD163 were similar between groups while iNos expression 
increased significantly in PVAT from rictorad-/- mice (Figure 4A). To validate this, we 
examined in cross sections of thoracic aorta with PVAT the expression of iNOS.  Indeed, 
iNOS expression was higher in the PVAT from rictorad-/- mice (Figure 4B). The uniform 
expression of iNOS across the PVAT suggests that adipocytes themselves and not 
macrophages are the predominant cells expressing iNOS. Moreover, iNOS staining in 
aortic medial layer was hardly visible. 
The percentages of macrophages and leukocytes in the vascular stromal fraction (SVF) 
were similar between groups in PVAT (Figure 4C). In EFAT, no differences in 
macropage and leukocyte percentages in SVF were detected, but overall percentages of 
macrophages and leukocytes were increased about 100% (Figure 4C).  
     
Inhibition of iNOS Restores Anticontractile Effect of PVAT 
TNFα stimulated iNos expression in 3T3-L1 adipocytes (Supplemental Figure IV) as 
reported previously.31 To confirm our observation that iNOS is expressed mainly in 
PVAT (Figure 4B, only background staining in the medial layer of the aorta), we 
analyzed gene expression of iNos in aortic tissue and PVAT. Indeed, expression of iNos 
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was only detected in PVAT but not in the aorta of rictorad-/- mice using quantitative real-
time PCR (CT value in PVAT: 29; aorta: no amplification). Thus, we investigated the 
possible role of iNOS for vascular function using  iNOS inhibitor 1400W.27 In aortic rings 
with PVAT, contractions in rictorad-/- mice were reduced in the presence of 1400W 
(Figure 5A) reaching similar levels detected in rictorfl/fl mice (Figure 5B). Additionally, 
treatment with 1400W improved the endothelium-dependent relaxation in aortic rings 
with PVAT from rictorad-/- mice (Figure 5C) to comparable levels observed in control rings 
(Figure 5D). Thus, the altered function in aortic rings with PVAT in rictorad-/- mice was 
normalized after inhibition of iNOS. Subsequently, we analyzed the effect of TNFα on 
PE-induced contractions, as this proinflammatory cytokine has been shown to 
counteract the anticontractile activity of PVAT.22 In aortic rings with PVAT from rictorfl/fl 
mice, contractions to PE (10-6 mol/L) increased in the presence TNFα but not to a similar 
level as contractions in the rings from rictorad-/- mice, which were significantly higher 
compared to untreated rings from rictorfl/fl mice (Supplemental Figure V). Thus, the 
increased contractility in rings with PVAT from rictorad-/- mice might be partially also due 
to increased TNFα secreted from PVAT. Taken together, our findings suggest that iNOS 
in concert with TNFα and possibly other inflammation-associated molecules counteract 
the intrinsic anticontractile function in PVAT of rictor ad-/- mice.  
 
Downregulation of Adipose Rictor Expression after High-Fat Diet Feeding 
Since depletion of rictor in adipose tissue is associated with increased expression of 
inflammatory genes and proteins in PVAT, we assessed the possible physiological 
relevance of rictor expressional regulation after high-fat diet (HFD) feeding, a model of 
experimental obesity and chronic low grade inflammatory disease.32  
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We analyzed rictor gene expression levels in PVAT and EFAT in mice fed for 10-12 
weeks with a HFD and with control diet (CD). Steady state mRNA expression levels of 
rictor were significantly downregulated in both types of adipose tissue after HFD (more 
than 30 %, Figure 6A, B; left panels). Concomitantly, iNos expression was significantly 
increased in PVAT of these HFD fed mice while in EFAT an upward trend was observed 
(P=0.16).  
 
Discussion 
In the present study, we describe a hitherto unknown function of the serine and 
threonine kinase complex mTORC2 controlling the anticontractile activity of PVAT 
primarily by regulating inflammation in the adipocytes. Downregulation of rictor, an 
essential mTORC2 component, in adipose tissue increased gene expression of Tnfα , 
Mip1α and iNos in PVAT and, concurrently increased the secretion of IL6, MIP1α and 
TNFα . Moreover, inhibition of iNOS restored the anticontractile activity of PVAT lacking 
rictor. Importantly, we demonstrate that in a model of low grade chronic inflammation, 
such as HFD-induced obesity, gene expression of rictor in PVAT is downregulated 
whereas that of iNOS is upregulated. 
Studies addressing PVAT’s contribution to vascular functions have largely focused on 
identifying molecules released by PVAT in normal and in pathological conditions such as 
obesity or hypertension.13, 30 Signaling enzymes in PVAT that control these secretory 
molecules are not yet known. To the best of our knowledge, this is the first study to show 
the contribution of an intracellular molecule (rictor) in adipocytes of PVAT in regulating 
the anticontractile activity.  
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Jabs et al. have shown that continuous treatment with the mTOR inhibitor rapamycin, 
also known as sirolimus, markedly reduced vasorelaxation to ACh in rat aortae devoid of 
PVAT by inducing endothelial dysfunction associated with reduced nitric oxide (NO) 
availability.33 Possible underlying mechanism may be inhibition of mTORC2 assembly in 
endothelial cells after long term rapamycin treatment34 impairing downstream signaling 
from Akt to eNOS.35, 36 In our study, depletion of rictor from adipose cells in PVAT 
increased aortic contractions in response to receptor-dependent vasoconstrictors and 
impaired vasorelaxation. Upon removing PVAT, the differences  in contraction and 
dilation between the groups vanished supporting the current model stating that PVAT-
released molecules directly mediate vasoactive effects.13         
PVAT can exert its anticontractile effects via endothelium-dependent or -independent 
mechanisms.17, 20  The endothelium-dependent effect involves release of NO from 
eNOS, which is required to maintain vascular tone, regulate platelet aggregation and 
leukocyte adhesion.37 In our model, the anticontractile function of rictor was still present 
in rings with intact PVAT after eNOS inhibition or endothelium denudation. Thus, 
endothelial NO or other endothelium-derived vasodilators do not play a major role in 
rictor’s anticontractile effects in PVAT. Inherent contractile responsiveness of vascular 
smooth muscle cells in the aortic rings was also preserved despite the loss of rictor in 
PVAT since KCl-induced contractions were identical. This suggests that mTORC2’s 
anticontractile effects in PVAT are most likely due to modulation of the secretory protein 
profile affecting adjacent vascular cells without changing their inherent functionality.  
Increased inflammation and/ or oxidative stress in PVAT have been linked to promote 
vasoconstriction and endothelial dysfunction.38, 39  In this regard, we screened the 
expression of reactive oxygen species generating NADPH oxidases and inflammatory 
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cytokines.  In PVAT lacking rictor, expression of only inflammatory cytokines was 
increased. Thus, in murine PVAT, decreased mTORC2 activity turned on a cascade of 
inflammatory pathways.  
Vascular expression of iNOS occurs during pathologic changes in the vascular wall such 
as atherosclerosis development, hypertension and vascular injury.40 These pathologies 
are often associated with inflammatory processes which induce expression of iNOS in 
the vascular wall. Healthy blood vessels do not express iNOS.41 Consistent with this 
finding, we did not detect iNOS expression in thoracic arterial tissue, i.e. endothelium 
plus VSMCs, without PVAT. Tian and co-workers have demonstrated that inhibition of 
iNOS protects endothelium/NO-dependent vasodilation of thoracic aorta in aged rats.42 
Vice versa, overexpression of iNOS using gene transfer resulted in impaired NO-
dependent vasorelaxation in carotid arteries.43 In our work, specific inhibition of iNOS 
with 1400W protected vasodilation and restored anticontractile activity in PVAT lacking 
rictor. Even though L-NAME inhibited iNOS by 40% still the contractions were higher in 
rings with PVAT lacking rictor. This suggests that partial inhibition of iNOS is not enough 
to restore anticontractile activity in PVAT.  
Why removal of PVAT expressing iNOS increase and not reduce contraction?  As 
explanation, we propose that the PVAT, expressing iNOS, also secretes anticontractile 
molecules acting on the smooth muscle cell layer. The release of procontractile 
molecules counteract but can’t abolish the overall anticontractile function, which is 
ultimately lost only after removal of PVAT 
The marked reduction in insulin-stimulated Akt phosphorylation in PVAT of rictor ad-/- 
mice may not only be caused by reduced mTORC2 to Akt signaling but may also be 
attributed to insulin resistance in these mice,10, 11 resulting in impaired insulin signaling 
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already at the level of the insulin receptor substrates.44 Brown and coworker have 
demonstrated that expression of a constitutively active Akt variant normalizes the 
hyperinflammatory phenotype in rictor-deficient cells by restoring mTORC2 downstream 
signaling.24 Thus, these increased inflammatory expression profiles, in our study, 
possibly may be caused by defective Akt signaling in PVAT lacking rictor. 
Infiltration of macrophages and T-cells in PVAT has been reported in mice fed with high-
fat diet.28, 30 In contrast, thoracic PVAT has also been reported to be relatively resistant 
to macrophage infiltration, to obesity-induced inflammation and is nearly identical to 
interscapular brown adipose tissue.45 In our study, when we compared the stromal 
vascular fractions of PVAT and EFAT from mice, we found about half as much 
leukocytes and macrophages in PVAT as compared with EFAT. This observation argues 
against an intrinsically pro-inflammatory depot in PVAT.  Moreover, there was no 
difference in macrophage presence in PVAT between rictorfl/fl and rictorad-/- mice. Thus, 
we suggest that ablation of rictor in adipocytes provide and promote a complementary 
source for propagation of inflammation. 
Obesity promotes inflammation in PVAT of thoracic aorta and in PVAT of other parts of 
the arterial tree.22, 46, 47 Increased expression of inflammatory cytokines such as TNFα 
and IL6 in PVAT of obese patients has been implicated to reduce its anticontractile 
activity.22 Intriguingly, in our model, experimental obesity induced via high-fat diet 
feeding per se downregulated gene expression of rictor in thoracic PVAT while iNos 
expression was upregulated.  Moreover, rictor deletion promoted a hyper-inflammatory 
phenotype in PVAT that resembles obesity-induced changes. We speculate that 
inflammation, possibly TNFα induces a series of signaling cascades in perivascular 
adipocytes resulting in downregulation of rictor expression. Furthermore, reduced 
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mTORC2 assembly and signaling in turn might further advance the ongoing 
inflammatory response.   
In conclusion, the present findings assign a decisive function to rictor in PVAT in 
protecting arteries from inflammatory stress and in controlling normal vascular function. 
Stabilizing expression of rictor in adipose tissue during obesity and other metabolic 
rearrangements might therefore embody a novel treatment approach to combat 
inflammation-associated vascular damage. 
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Significance 
Perivascular adipose tissue (PVAT) surrounds most arteries and has anticontractile 
function. Increased inflammation in the vasculature associated PVAT is present during 
hypertension, atherosclerosis and obesity. Our study reveals a yet unexplored function 
of rictor, an essential component of mTOR complex 2, in perivascular adipocytes to 
regulate anticontractility via inhibiting the expression of inflammatory cytokines and 
iNOS. Our results suggest a direct gate keeper function for perivascular adipose 
mTORC2 in mediating vascular inflammation. The present findings underscore the 
importance to address mTORC2 signaling during inflammation-induced vascular 
damage. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Adipose cell-specific deletion of rictor 
results in decreased expression of rictor and 
reduced Akt phosphorylation in PVAT. (A) 
Steady state mRNA expression levels of rictor 
in PVAT (n=9/10) and aortic tissue (n=4) were 
determined in rictorfl/fl and rictorad-/- mice using 
quantitative real-time PCR. (B) Immunoblot  
analysis of insulin-stimulated phosphorylation 
of Akt at Ser473 and Erk1/2 in PVAT and aorta 
from rictorfl/fl  and rictorad-/- mice. Total Akt and 
Erk2 were used to control for protein loading. 
One representative blot out of three is shown. 
(C) Quantification of pAkt in PVAT and aorta 
from rictorfl/fl and rictorad-/- mice (n=3). 
Densitometric analysis was first normalized to 
total Akt and then to untreated rictorfl/fl . All data 
represent means ± SEM. *P<0.05 vs. rictor fl/fl. 
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Figure 2. Rictor controls anticontractility in PVAT. Aortic rings from rictorfl/fl and rictorad-/- 
mice were used. Rings with  PVAT (A) or without PVAT (B) were contracted with PE  
(10-9 – 3x10-6 mol/L) in a concentration-dependent manner (n=10-13). Rings with PVAT 
(C) or without PVAT (D) were pre-contracted with PE and treated with Ach (10-9 – 3x10-6 
mol/L) in a concentration-dependent manner (n=7-13). (E) Aortic rings with  PVAT were 
pre-treated with L-NAME (300 x10-6 mol/L) and then contracted with PE in a 
concentration-dependent manner (n=5-13). (F and G) Aortic rings with PVAT but without 
endothelium were treated in a concentration-dependent manner with PE or with 3x10-6 
mol/L of PGF2α (n=6-9).  All Values are means±SEM. *P<0.05 vs. rictorfl/fl  
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Figure 3. Adipocyte-specific deletion of rictor increases expression of 
inflammatory molecules in PVAT. (A) Steady state mRNA expression levels of 
adipokines, ROS, adipocyte differentiation and inflammatory molecules as 
determined by quantitative real-time PCR. Results are normalized to the levels in 
PVAT from rictorfl/fl mice (n=4-8). (B) Protein concentrations of inflammatory 
cytokines released by PVAT were determined in conditioned media using  
Bioplex  system (n=4). All values represent means ± SEM, *P<0.05 vs. rictorfl/fl  .  
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Figure 4. Elevated iNOS expression in PVAT from rictorad -/- mice is 
independent of macrophage infiltration. (A) Steady state mRNA 
expression levels of emr (F4/80), CD163, and iNos were determined by 
quantitative real-time PCR. Results are normalized to the levels in 
PVAT from rictorfl/fl mice (n=8-14), *P<0.05 vs. rictorfl/fl. (B) 
immunofluorescence staining of iNOS (red) in cross sections of thoracic 
aorta with PVAT from rictorfl/fl (upper panel) and rictorad-/- (lower panel) 
mice. Arrow heads indicate medial layer. Scale bar, 100 μm. Images are 
representative of n≥3 mice. (C), Percentages of macrophages (F4/80 
and CD45.2 positive cells) and leukocytes (CD45.2 positive cells) in 
SVF from PVAT and EFAT using flow cytometry, data are means ± 
SEM, n=4-5, *P<0.05 . All values represent means ± SEM. 
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Figure 5. Inhibition of iNOS in PVAT normalizes vascular reactivity in 
rictorad-/- mice. (A and B) Aortic rings with PVAT from rictorad-/- and 
rictorfl/fl mice were contracted with PE in the presence or  absence of 
iNOS inhibitor 1400W. rictorad-/- pD2: 5.4±0.2 mol/L vs. rictorad-/-
+1400W pD2: 4.8±0.2 mol/L (n=11-13) *P<0.05 vs. rictorad-/- by pD2. (C 
and D) Precontracted aortic rings with PVAT were relaxed using ACh  
in the presence or absence of 1400W (n=7-13), *P<0.05 vs. rictorad-/- .  
All values are means±SEM..  
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Figure 6. Differential effects of high-fat diet feeding on 
expression of rictor and iNOS in different fat depots. Steady 
state mRNA expression levels of rictor and iNos in PVAT 
(A) and EFAT (B) of mice fed with control diet (CD, n=5-9) 
or high-fat diet (HFD, n=6-9). Results are normalized to the 
levels from mice fed CD. Values are means±SEM. *P<0.05 
vs. CD.  
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Materials and Methods 
 
 
Mice  
The mice used in the present study were described before in detail.1 Briefly, mice with 
adipose-specific deletion of rictor (rictorad−/−) were generated by crossing rictorfl/fl mice with 
C57BL/6J mice expressing Cre recombinase under the control of the adipocyte-specific 
fabp4/aP2 gene promoter (purchased from JAX Laboratories, Bar Harbor, Maine, USA). 
Male mice (5 months) were used for all experiments which were backcrossed at least 5 times 
with the C57BL/6J strain except for flow cytometry analysis for which female mice (5-6 
months) were used. Littermates with the lox/lox genotype (rictorfl/fl) were used as control 
group in all experiments. Mice were housed at the institutional animal facilities (University 
Hospital Zurich and Biozentrum Basel, Switzerland, respectively) with a 12 hour light/dark 
cycle. Animals had access to standard chow (4.5% calories from fat; Kliba Nafag, 
Kaiseraugust, Switzerland) and to water ad libitum. Another group of male mice 8 weeks of 
age were fed high-fat diet (60% calories from fat; Harlan Research Diets) for 10-12 weeks.  
All mice used were genotyped with specific primers using PCR and standard protocols. 
Before sacrifice, mice were weighed and anesthetized by i.p. injection (xylazine: 100; 
ketamine: 23; and acepromazine: 3.0; in mg/kg body weight) and exsanguinated via cardiac 
puncture. Mice used for vascular function and insulin stimulation experiments were starved 
overnight. All mouse experiments described here were approved by the Kantonales 
Veterinaeramt of Basel-Stadt and Zurich, Switzerland, respectively.  
 
Cell Culture 
3T3-L1 cells were cultured in DMEM medium (Biochrome AG, Berlin, Germany) 
supplemented with 10% FCS and differentiated to adipocytes as described.2 Briefly, post-
confluent 3T3-L1 cells were treated with 3-isobutyl-1-methylxanthine (500 µM), 
dexamethasone (0.25 µM), insulin (10 µg/ml) and rosiglitazone (2 µM) for 2 days. Thereafter, 
cells were treated with insulin (1 µg/ml) for next 2 days. The cells were then maintained in 
DMEM medium with 10% FCS for 6 additional days and the media was changed every 2nd 
day. Differentiated adipocytes were kept overnight in DMEM medium with 0.5% FCS and 
then stimulated without or with TNFα (10 ng/ml) for 24 h.  RAW264.7 cells were cultured in 
DMEM medium with 10% FCS.  
 
Nitric Oxide Measurement 
Nitric oxide is converted to nitrate and nitrite in the cell and is released in the conditioned 
media. RAW264.7 cells were treated with lipopolysaccharide for 24h in the absence or in the 
2 
 
presence of L-NAME (300 µM) or 1400W (1µM). In the conditioned media, nitrite 
concentrations were determined using Griess reagent (Sigma-Aldrich Chemie GmbH, Buchs, 
Switzerland) and optical density was measured at 540 nm. The amount of nitrite in the 
culture media was quantified using sodium nitrite as a reference standard. 
 
RNA Isolation and Quantitative PCR  
RNA isolation, cDNA preparation and real-time quantitative PCR were performed from 
epididymal fat, thoracic PVAT and aortae using standard protocols. Briefly, RNA from fat 
tissues was extracted using RNeasy lipid tissue mini kit and from aorta using RNeasy fibrous 
tissue kit according to the protocol of the manufacturer (Qiagen, Hombrechtikon, 
Switzerland). Total RNA was transcribed into cDNA using WT (Whole Transcript)-Ovation™ 
Pico RNA Amplification System from NuGEN (Bemmel, Netherlands). Quantitative real-
timepolymerase chain reaction (qRT-PCR) was performed using specifically designed mouse 
primer pairs for the genes analyzed in the present study (Table S1). Gene expression in 
epididymal fat and PVAT was normalized to acidic ribosomal phosphoprotein (Arbp) and in 
aortic tissue to β-actin using the comparative C(T) method.3  
 
Vascular Function Analysis 
Experiments were performed as described before.4, 5  After sacrifice, thoracic aorta was 
dissected, placed in cold (4°C) Krebs-Ringer bicarbonate solution (in mmol/l: NaCl 118.6; 
KCl 4.7; CaCl2 2.5;MgSO4 1.2; KH2PO4 1.2; NaHCO3 25.1; EDTANa2Ca 0.026; glucose 10.1). 
To check the effect of PVAT on vascular function, aorta was either cleaned of adhering 
PVAT or was left intact. Aorta with or without fat was cut into equal-sized rings (2.5 mm of 
length) under a dissection microscope (Olympus SZX9, Volketswil, Switzerland), and care 
was taken not to damage the endothelium during preparation. Rings were mounted on 
tungsten wires (100 µm in diameter) and placed vertically in water-jacketed organ chambers 
containing 10 ml of Krebs buffer maintained at 37°C and pH 7.4 with constant gassing (95% 
O2 and 5% CO2). One end of each wire was fixed to a stainless steel rod, and the other end 
was connected to force transducers (Hugo Sachs Electronik, March-Hugstetten, Germany). 
Rings were stretched in a stepwise manner until a resting tension of 3.5 g was achieved. 
Stretched rings were allowed to equilibrate for 30 min before exposing with KCl (100 mmol/L) 
until a stable contractile response was reached.  The rings were exposed to phenylephrine 
(PE; 10-9- 3x10-6 mol/L), prostaglandin2α (PGF2α; 10-6- 3x10-6 mol/L) or acetylcholine (ACh; 
10-9-10-4 mol/L) in a concentration-dependent manner.  To block nitric oxide synthase (NOS) 
selected aortic rings were treated with either NG-nitro-L-arginine methyl ester (L-NAME; 
300x10-6 mol/l) 4 or with iNOS inhibitor (1400 W, 10-6 mol/L).6 
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To check the vascular smooth muscle cells-dependent contractile responses, aortic rings 
with PVAT were exposed to increasing concentration of KCl (10 to 100 mmol/L). 
For endothelial denudation experiments, selected rings were exposed for 10 sec to 1% Triton 
X-100 before mounting into the organ chamber. Endothelial denudation was tested by 
treating PE -precontracted rings with ACh followed by treatment with sodium nitroprusside 
(10-5 mol/L), a nitric oxide donor.  
 
 
Insulin stimulation and Immunoblotting  
Aortic rings with PVAT were mounted to organ chambers and stretched as described above. 
After 30 min of equilibration, tissues were stimulated with insulin (1µmol/L). After 10 min, 
tissues were transferred into ice cold Krebs Ringer buffer and PVAT was separated from the 
aortic tissue. Both tissues (PVAT or aorta without PVAT) were homogenized using Qiagen 
tissue lyser in lysis buffer containing Tris.Cl (50 mmol/L, pH 7.4), NaCl (150 mmol/L), EDTA 
(1 mmol/L), NP-40 (1%), protease inhibitor, and phosphatase inhibitor cocktail (Sigma, 
Buchs, Switzerland). Equal amounts of protein were loaded for SDS-PAGE, transferred to 
nitrocellulose and analyzed with the indicated antibodies. Immunoblotting was performed 
using the antibodies against phospho Akt (pSer473), Akt and phospho Erk1/2  (Cell 
Signaling, Danver, MA, USA) and ERK2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
and corresponding HRP-conjugated secondary antibodies (GE Healthcare, 
Buckinghamshire, UK). Labeled proteins were visualized on X-ray films using a 
chemiluminescence reaction. Quantification of blots was performed by using the software 
ImageJ 1.40g (NIH, USA). 
 
Bioplex Assay 
Thoracic aortic PVAT was excised and incubated in a 96- well plate containing 200µl Phenol 
Red-free and serum-free DMEM/Ham’s F-12 medium (BioConcept Amimed, Allschwill, 
Switzerland) for 48h. Conditioned media was collected, shock-frozen in liquid nitrogen and 
stored at -80°C. Concentrations of MIP-1α, TNFα and IL-6 levels in the conditioned media 
were determined using BioPlex Pro Mouse cytokine Group 1 (customized 3-plex assay, 
BioRad, Hercules CA, USA) according to the recommendations of the manufacturer. Data 
were analyzed using the BioPlex Manager 4.1.1 software. Cytokine concentration in PVAT 
was quantified based on Logistic-5PL regression standard curve. Values were normalized to 
protein content in the conditioned media. 
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Immunofluorescence analysis of cryosectios 
Thoracic aortae with PVAT from rictorad-/- and rictorfl/fl mice were embedded in Tissue Tec 
(Sakura, Germany) and stored at –80°C. Cross sections (10 μm) were cut using a cryostat 
and mounted on superfrost plus slides (Thermo Fisher, Germany). Slides were used directly 
for immunofluorescence analysis or stored at - 80°C until needed. Before staining, slides 
were dried at room temperature (RT) for 20 minutes and fixed with 4 % PFA in PBS 
(pH 7.4) for 10 minutes. Slides were washed twice for 5 minutes in PBS (pH 7.4). Sections 
were incubated in blocking buffer (0.1% Tween 20, 5% goat serum in PBS) for 60 minutes at 
RT to block non-specific binding of immunoglobulin. Sections were incubated with iNOS 
primary antibody overnight at 4°C (Abcam; ab15323; 1:350 in blocking buffer) in a humidified 
chamber. Next day, slides were washed three times for 5 min in wash buffer (0.1% Tween20 
in PBS). Sections were incubated with Alexa 568 secondary antibody (Invitrogen; A-11036) 
diluted 1:500 in blocking buffer for 30 minutes at RT in the dark and humidified chamber. 
Slides were rinsed in wash buffer three times for 5 minutes. Coverslips were mounted with 
Darko Fluorescence mounting medium (Darko, USA) onto slides. Slides were dried at least 1 
day before imaging and kept at 4°C. Images were acquired using CLSM Leica SP5 
microscope and LAS-AF 3.X software (Leica, Germany). 
 
Isolation of the stromal vascular fraction from adipose tissue and flow cytometry 
PVAT from thoracic aortae and epididymal adipose tissues (EFAT) were harvested, and 
digested enzymatically by incubation in a solution containing collagenase type D from 
clostridium histolyticum (0.5 mg/ml, Roche Diagnostics, Indianopolis, USA) dissolved in PBS 
supplemented with CaCl2 2.5 mmol/L for 1 hour at 37°C with constant agitation (900 rpm). 
After 30 minutes, tissues were passed 10 times through an 18g needle and, at the end of the 
incubation period, through a 30 µm sterile cell strainer (Miltenyi Biotec) to yield a single cell 
suspension corresponding to the vascular stromal fraction. Cells were washed and 
suspended in flow cytometry buffer (0.5% BSA, 1mM EDTA in PBS) containing of the 
following antibodies: fluorescein isothiocyanate anti-CD45.2 (1:200 Biolegend) and APC-
AlexaFluor750 anti-F4/80 (1:100, Biosciences). After immunostaining (incubation with 
labeled antibodies for 40 minutes at 4°C in the dark), cells were washed 2 times in flow 
cytometry buffer and  cell populations were analyzed by BD FACS Canto run with DIVA 
software (Becton Dickinson). Data were analyzed with FlowJo software 8.5.2, (Tree Star). 
Percentages of macrophages (CD45+ F4/80+) in the stromal vascular fraction from the 
different adipose tissues was determined.  
Statistical Analysis 
Data are expressed as means ± standard error of the mean (SEM). Vascular function 
experiments were analyzed with ANOVA for repeated measurements followed by a 
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Bonferroni post-hoc test. Contractions are given as a percentage of contraction to 
100 mmol/L KCl, and dilations as a percentage of the maximal pre-contraction. pD2 (-log 
EC50) values were calculated with non-linear regression analysis. Comparisons between 
groups for remaining experiments were analyzed by two-tailed Student’s t-test. Differences 
were considered statistically significant at values of P <0.05. All statistical analysis was 
performed using GraphPad Prism 5.04 program for Windows (GraphPad software, San 
Diego, CA, USA).  
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Supplementary Table 1 
 
Primer list for quantitative real-time PCR 
 
Gene  Forward primer (5'-3') Reverse Primer (5'-3') 
Arbp AGCTGAAGCAAAGGAAGAGTCGGA ACTTGGTTGCTTTGGCGGGATTAG 
Rictor  TGCGATATTGGCCATAGTGA ACCCGGCTGCTCTTACTTCT 
Adipoq GCACTGGCAAGTTCTACTGCA AACA AGAGAACGGCCTTGTCCTTCTTGA 
Retn  GCAAGGATAGACTGGACAGCA AGACCGGAGGACATCAGACA 
lnc2  CACCTCCATCCTGGTCAGGGA C TCCGTGGTGGCCACTTGCAC  
Nox2 AACTCCTTGGGTCAGCAGTG GAGCAACACGCACTGGAAC 
Nox4 GTGAAGATTTGCCTGGAAGAA C TGATGACTGAGATGATGGTGAC 
Il6 CCATCCAGTTGCCTTCTTG AATTAAGCCTCCGACTTGTG 
Mip1a ACTGACCTGGAACTGAATGCCTGA ATGTGGCTACTTGGCAGCAAACAG 
Tnf GCGGTGCCTATGTCTCAG GCCATTTGGGAACTTCTCATC 
Nos2 GCACCGAGATTGGAGTTC AGCACAGCCACATTGATC 
β-actin CGTGCGTGACATCAAAGAGA CCCAAGAAGGAAGGCTGGA 
 
 
 
 
Insert missing primers 
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Supplemental Figures 
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Supplemental Figure I: Steady state 
mRNA expression levels of rictor in 
epididymal fat were determined using 
quantitative real-time PCR in rictor 
fl/fl 
and 
rictor 
ad-/- 
mice. Data represent means ± 
SEM, n=5; *P<0.01.  
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  Supplemental Figure II: KCl-induced 
contractions. Aortic rings with PVAT from 
rictor
fl/fl
 or rictor
ad-/- 
mice were contracted with 
KCl in a concentration-dependent manner (10-
100 mmol/L). Data represent means ± SEM, 
n=4-5. 
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Supplemental Figure III: Inhibition of LPS-
induced NO production by 1400W and L-
NAME in macrophages. Murine macrophage 
RAW 264.7 cells were treated with 1400W 
(10-6 mol/L) or L-NAME (300x10-6 mol/L). After 
45 min, cells were stimulated with LPS (1 
µg/ml) as indicated. Conditioned media was 
collected and nitrate levels were determined. 
Data represent means ± SEM, n=3; *P<0.05 
vs. LPS. 
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Supplemental Figure IV: TNFα 
stimulation increases gene expression 
of iNOS. Steady state mRNA expression 
levels of iNos were determined by 
quantitative real-time PCR in 3T3-L1 
adipocytes stimulated with TNF (10 ng/ml). 
Values represent means ± SEM, n=5. 
*P<0.05 
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Supplemental Figure V: TNFα increases 
PE-mediated contration. Aortic rings with 
PVAT from rictor
fl/fl
 mice were pre-treated 
with or without TNF (10 ng/ml) and then 
contracted with PE (10
-6
 mol/L). As 
reference, aortic rings with PVAT from 
rictor
ad-/-
 mice were used Values are 
means±SEM, n=4; *P<0.05 vs. rictor
fl/fl
 
without TNF. 
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